iBio, Inc.
IBIONasdaqCIK 1420720HealthcareFiscal year ends Jun 30
Reports and events: 361 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-10-1920:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001420720-26-000032 |
| 2026-10-1312:25 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-26-000030 |
| 2026-09-1420:16 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-26-000028 |
| 2026-09-0420:05 ET | DEF 14A | Proxy statementPeriod 2026-09-04 | 0001420720-26-000022 |
| 2026-08-2812:32 ET | 10-K | Annual reportPeriod 2026-06-30 | 0001420720-26-000020 |
| 2026-08-2812:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001420720-26-000019 |
| 2026-08-0411:05 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-26-000014 |
| 2026-07-1720:08 ET | 8-K | 5.08 Item not in the standard list; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-26-000012 |
| 2026-07-0111:33 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-26-000010 |
| 2026-05-1220:18 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001104659-26-059416 |
| 2026-05-1220:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001104659-26-059408 |
| 2026-05-0820:16 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-057945 |
| 2026-04-1721:13 ET | 8-K/A | 8.01 Other events | 0001104659-26-044969 |
| 2026-04-0813:00 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-040703 |
| 2026-03-0911:04 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-26-000006 |
| 2026-02-2721:49 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001104659-26-021654 |
| 2026-02-1021:16 ET | 10-Q | Quarterly reportPeriod 2025-12-31 | 0001420720-26-000004 |
| 2026-02-1021:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001420720-26-000003 |
| 2026-01-1222:29 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-26-002940 |
| 2025-11-2113:09 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-114800 |
| 2025-11-1721:32 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000045 |
| 2025-11-1712:40 ET | 10-Q/A | Quarterly report, amendedPeriod 2025-09-30 | 0001420720-25-000043 |
| 2025-11-1221:14 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001420720-25-000041 |
| 2025-11-1221:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001420720-25-000039 |
| 2025-11-0421:03 ET | 8-K | 8.01 Other events | 0001420720-25-000035 |
| 2025-10-3011:29 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000033 |
| 2025-10-0621:15 ET | DEF 14A | Proxy statementPeriod 2025-11-20 | 0001104659-25-097166 |
| 2025-09-0513:30 ET | 10-K | Annual reportPeriod 2025-06-30 | 0001558370-25-011888 |
| 2025-09-0513:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-25-011885 |
| 2025-08-2120:11 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-081419 |
| 2025-08-1820:24 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-079816 |
| 2025-08-0120:47 ET | 8-K | 3.01 Delisting notice | 0001558370-25-009992 |
| 2025-06-2411:56 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000029 |
| 2025-06-1811:22 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000027 |
| 2025-05-0212:29 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001420720-25-000025 |
| 2025-05-0212:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001420720-25-000024 |
| 2025-04-2220:41 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001420720-25-000020 |
| 2025-04-0811:30 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000018 |
| 2025-04-0711:01 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000016 |
| 2025-02-1921:25 ET | 8-K | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001420720-25-000014 |
| 2025-02-1021:15 ET | 10-Q | Quarterly reportPeriod 2024-12-31 | 0001420720-25-000012 |
| 2025-02-1021:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001420720-25-000010 |
| 2025-01-1312:55 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000005 |
| 2025-01-1012:47 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001420720-25-000003 |
| 2025-01-0212:36 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001420720-25-000001 |
| 2024-11-2513:30 ET | 8-K | 2.02 Results of operations; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-122387 |
| 2024-11-1221:27 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001420720-24-000054 |
| 2024-11-1221:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001420720-24-000053 |
| 2024-10-2313:12 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001420720-24-000049 |
| 2024-10-1020:10 ET | DEF 14A | Proxy statementPeriod 2024-10-10 | 0001420720-24-000046 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:09 ET. Listed shows no prices and gives no investment advice.